Following Cynthia Zipperle’s last HUM Sell transaction on March 12, 2018, the stock climbed by 38.7%. In addition to Cynthia Zipperle, one other HUM executive reported Sell trades in the last month.
Based on Humana Inc’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $14.28 billion and quarterly net profit of $491 million. In comparison, last year the company earned revenue of $13.76 billion and had a net profit of $1.12 billion. HUM’s market cap is $42.19B and the company has a P/E ratio of 24.09. Currently, Humana Inc has an average volume of 266K.
Five different firms, including BMO Capital and Citigroup, currently also have a Sell rating on the stock. Based on 6 analyst ratings, the analyst consensus is Strong Buy with an average price target of $316.67, reflecting a -3.4% downside.
The insider sentiment on Humana Inc has been negative according to 56 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Humana Inc. is a health and well-being company focused on making it easy for people to achieve best health. Its strategy integrates care delivery, the member experience, and clinical & consumer insights to encourage engagement, behavior change, proactive clinical outreach, and wellness for the people.